Cancer vaccines.
Cancer vaccines.
复制标题
DOI：
10.1016/j.ccell.2022.05.015
复制
发表时间：
2022-06-13
期刊：
影响因子：
50.3
通讯作者：
Lowy, Douglas R.
中科院分区：
文献类型：
--
作者：
Schiller, John T.;Lowy, Douglas R.
鉴于COVID-19大流行重新激发了对疫苗开发的兴趣，我们正在重新审视癌症预防和治疗疫苗开发的现状。专家们讨论了不同的疫苗类型，它们的抗原和作用模式，以及我们在临床开发中的立场，以及我们在广泛实施中需要克服的挑战。鉴于COVID-19大流行重新激发了对疫苗开发的兴趣，我们正在重新审视癌症预防和治疗疫苗开发的现状。专家们讨论了不同的疫苗类型，它们的抗原和作用模式，以及我们在临床开发中的立场，以及我们在广泛实施中需要克服的挑战。
Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation. Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation.